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The relationship between preoperative creatinine
clearance and outcomes for patients undergoing
liver transplantation: a retrospective observational
study
Urs Wenger1†, Thomas A Neff1†, Christian E Oberkofler2, Manuel Zimmermann1, Paul A Stehberger1,
Marcel Scherrer1, Reto A Schuepbach1, Silvia R Cottini1, Peter Steiger1 and Markus Béchir1*
Abstract
Background: Renal failure with following continuous renal replacement therapy is a major clinical problem in liver
transplant recipients, with reported incidences of 3% to 20%. Little is known about the significance of postoperative
acute renal failure or acute-on-chronic renal failure to postoperative outcome in liver transplant recipients.
Methods: In this post hoc analysis we compared the mortality rates of 135 consecutive liver transplant recipients
over 6 years in our center subject to their renal baseline conditions and postoperative RRT. We classified the
patients into 4 groups, according to their preoperative calculated Cockcroft formula and the incidence of
postoperative renal replacement therapy. Data then were analyzed in regard to mortality rates and in addition to
pre- and peritransplant risk factors.
Results: There was a significant difference in ICU mortality (p=.008), hospital mortality (p=.002) and cumulative
survival (p<.0001) between the groups. The highest mortality rate occurred in the group with RRT and normal
baseline kidney function (20% ICU mortality, 26.6% hospital mortality and 50% cumulative 1-year mortality,
respectively). The hazard ratio in this group was 9.6 (CI 3.2-28.6, p=.0001).
Conclusion: This study shows that in liver transplant recipient’s acute renal failure with postoperative RRT is
associated with mortality and the mortality rate is higher than in patients with acute-on-chronic renal failure and
postoperative renal replacement therapy.
Keywords: Acute renal failure, Acute on chronic renal failure, Renal replacement therapy, Liver transplantation
Background
Renal failure with following continuous renal replacement
therapy (RRT) is a major clinical problem in liver trans-
plant recipients with reported incidences of 3% to 20%
[1-3]. Apart from higher costs renal failure is associated
with increased mortality in ICU patients in general [4]
and in particular in liver transplant recipients, varying
from 27% to 67% depending on the comorbidities [5-7].
Preoperative renal dysfunction increases the intra-
operative complications and is a strong predictor of
mortality [8]. Gonwa et al. reported that 35% of liver
transplant recipients with hepatorenal syndrome (HRS)
needed RRT postoperatively versus only 5% without HRS
[9]. Although TPL can correct HRS, interestingly the renal
function often recovers only to a glomerular filtration rate
of 30-40 ml/min. Potential explanation seems to be the
administration of immunosuppressants in these cases
[10,11]. Furthermore, renal failure is leading to prolonged
hospital stay, increased rate of rejection and rate of infec-
tion in liver transplant recipients [8]. There are many
reports regarding preoperative renal function, especially
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the role of preoperative creatinine serum levels in post-
operative outcomes in liver transplant recipients [12-14].
Apart from preexisting renal impairment, i.e. HRS [15],
there are other stressors for the kidneys: Intraoperative oc-
currence of hypotension with/or without hypovolemia
may reduce renal perfusion [16] and operation without
veno-venous bypass may lead to renal congestion resulting
in further renal injury [17]. Postoperatively used nephro-
toxic agents like antibiotics or immunosuppressants may
further contribute to progressive renal failure [18]. There-
fore, it is difficult to distinguish between pretransplant
and peritransplant factors contributing to the pathoge-
nesis of renal failure resulting in RRT in liver transplant
recipients. The calculated Cockcroft formula is easy to
assess and is of clinical importance because for instance
renal impairment dosages of drugs are estimated by calcu-
lating the estimated creatinine clearance using this
formula. Little is known about the significance of the pre-
operative calculated Cockcroft formula in assessing
postoperative outcome in liver transplant recipients.
There are concerns about its use in the context of
advanced cirrhosis or fulminant liver failure [19]. There-
fore, in this post hoc analysis we compared the mortality
rates of 135 consecutive liver transplant recipients over 6
years in our center subject to their renal baseline
conditions and postoperative RRT. Furthermore, we tried
to identify pre- and perioperative risk factors for the deve-
lopment of acute or acute-on-chronic renal failure after
liver transplantation.
Methods
We included 135 consecutive liver transplant recipients
between January 1, 2003 and December 31, 2008 operated
in our center. Following approval by the local Ethics (KEK
4 Kantonale Ethikkomission, Abt. 4) all patients gave
written informed consent before transplantation for data
analysis post transplantation.
Inclusion/exclusion criteria
We included all adult (>16 years) regularly and high ur-
gently listed liver transplant recipients between January 1,
2003 and December 31, 2008 in our transplantation cen-
ter. Exclusion criteria were retransplantation, combined
transplantations (e.g. liver and kidney), renal replacement
therapy before TPL, preexisting kidney transplantation
and living donor related liver transplant recipients.
Pretransplant recipient data
As baseline characteristics we analysed age, gender, BMI,
creatinine, creatinine clearance estimated by Cockcroft
formula, haematocrit and platelet count. Normal creatin-
ine clearance was defined as > 60 ml/min. Furthermore,
the following clinical data were collected: Underlying liver
disease, MELD score [20] (corrected and uncorrected)
[21], Child classification of liver cirrhosis, incidence of
diabetes mellitus and location directly before TPL (home,
hospital or ICU).
Operative data
All patients were transplanted without veno-venous by-
pass, as described by McCormack et al. [22]. Patient
records were analysed in respect to ASA class, operating
time, estimated intraoperative blood loss, transfusion of
RBC, FFP or platelets intraoperatively and the application
of Fibrinogen.
Marginal grafts were defined as either age ≥ 65 years or
cold ischemia time ≥ 720 min or biopsy-proven steatosis
(micro- or macrovascular in ≥ 60% of hepatocytes or
≥ 30% macrovascular steatosis) [23,24].
ICU data
The following data were collected: Serum peak values of
bilirubin, ALT and AST, length of stay in the ICU, re-
admission rate to the ICU, postoperative serum creatinine
peak level, incidence of renal replacement therapy, inci-
dence of sepsis defined according to the international
guidelines [25], incidence of pulmonary failure (ARDS
defined according to the AECC definition [26], pneumo-
nia in need of reintubation), incidence of reoperations
during ICU stay.
Post-hoc analyzing protocol
After collection of this data we classified the patients into
4 groups, according to (1) their preoperative calculated
Cockcroft formula and (2) the postoperative need of RRT.
(We used the equation: (140-age)*body weight/creatinine
{mg/dl}*72 for Cockcroft formula (multiplied with 0.85 in
the case of women):
Group 1: Calculated Cockcroft formula > 60 ml/min
with postoperative RRT.
Group 2: Calculated Cockcroft formula > 60 ml/min
without postoperative RRT.
Group 3: Calculated Cockcroft formula < 60 ml/min
with postoperative RRT.
Group 4: Calculated Cockcroft formula < 60 ml/min
without postoperative RRT.
We calculated and compared the ICU mortality, hos-
pital mortality and mortality overall and analysed the
cumulative survival of the 4 different groups.
Then we performed univariate analysis of risk factors
between the groups with normal creatinine clearance
(group 1 and 2) and decreased creatinine clearance (group
3 and 4), respectively.
Statistical analysis
The between group comparisons were made with Mann
and Whitney U-test for continuous variables and Chi-tests
for nominal variables. Cumulative survival analysis was
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done by the method of Meier Kaplan. All calculation and
analysis were done with Stat view 4.5 (abacus concepts,
Berkeley, CA, USA). Statistical significance was accepted
with p< 0.05 (two sided tests).
Results
Distribution of the groups
The number of 135 patients was assigned to the 4
groups as follows: Group 1 consisted of 15 (11.1%)
patients, group 2 of 85 (63.0%), group 3 of 10 (7.4%) and
group 4 consisted of 25 (18.5%), respectively. Baseline
characteristics and diagnoses are given in Tables 1 and 2.
Mortality
There was a significant difference in ICU mortality
(p=.008), hospital mortality (p=.002) and overall mortality
(p=.015) between the groups. Interestingly, the highest
mortality rate occurred in the group with RRT and normal
baseline kidney function (20% ICU mortality, 26.6%
hospital mortality and 50% cumulative 1-year survival, re-
spectively). For details see Figure 1 and Table 3.
Differences between acute renal failure with RRT and
acute-on-chronic renal failure with RRT in regard on the
risk of mortality
The hazard ratio in the group 1 (acute renal failure with
RRT) was 9.6 (CI 3.2-28.6, p=.0001) and in the group 3
(acute-on-chronic renal failure with RRT) 5.6 (CI 0.5-62.5,
p=.15).
Which factors contributed to RRT in patients with
“normal” baseline kidney function (group 1, acute renal
failure)?
In 15 out of 100 patients (15.0%) with normal preoperative
kidney function RRT was necessary during the ICU stay.
Univariate analysis revealed BMI (p=.05), hematocrit
before TPL (p=.014) and MELD score (p=.014) as pre-
operative risk factors for RRT after transplantation.
Intraoperatively, the estimated blood loss (p=.05) was a
risk factor for RRT and there was a trend towards fi-
brinogen application (p=.08). Furthermore, there were
on one hand significant different AST (p=.015) and ALT
(p=.022) peak levels and on the other hand significant
increased bilirubin (p=.003) and alkaline phosphatase
(p=.002) peak serum levels in the group with RRT
(group 2) versus the group without RRT (group 2).
In the ICU the patients requiring RRT postoperatively
(group 1) had significant more sepsis (p=.0001) and
Table 1 Baseline characteristics (n=135)
Men/women 104/31
Age (yrs.) 51.1±12.0 (18.0–70.5)
Weight (kg) 77.6±16.0 (43.0–136.0)
Height (m) 1.73±0.10 (1.50–1.95)
BMI (kg/m2) 25.8±4.3 (16.0–36.0)
Creatinine (μmol/l) 99±44 (40–306)
Hematocrit (%) 32.4±6.6 (19.3–49.6)
Platelets (103/μl) 103±60 (22–285)
Data expressed as mean ± SD (range).
Table 2 Underlying liver diseases (n=135)
HCV liver cirrhosis overall 51 (37.7%)
HCV liver cirrhosis + HCC 18 (12.8%)
HBV liver cirrhosis overall 13 (9.6%)
HBV liver cirrhosis +HCC 6 (4.4%)
HCC overall 37 (27.4%)
Alcoholic liver cirrhosis overall 24 (17.7%)
Alcoholic liver cirrhosis + HCC 1 (0.7%)
PSC 5 (3.7%)
PBC 4 (2.9%)
Wilson’s disease 4 (2.9%)
Cryptogenic liver cirrhosis 2 (1.5%)
Amyloidosis 3 (2.2%)
Budd chiari syndrome 2 (1.5%)
Alpha-1-antitrypsin deficiency 1 (0.7%)
AIH liver cirrhosis 1 (0.7%)
Osler’s disease 1 (0.7%)
Other 2 (1.5%)
Acute liver failure 11 (8.1%)
HCV indicates hepatitis C virus, HBV hepatitis B virus, HCC hepatocellular
carcinoma, PSC primary sclerosing cholangitis, PBC primary biliary cirrhosis and
AIH autoimmune hepatitis, respectively.
0
0
250 500 750
Time (days)
.2
.4
.6
.8
1
Su
rv
iv
al
1
2
3
4
Figure 1 Kaplan Meier curve of the 4 groups: There were
significant different survival rates. The lowest cumulative survival
shows group 1, with preoperative normal kidney function and
postoperative renal replacement therapy (p<.0001, log rank test).
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respiratory failure with the need for reintubation
(p=.009); had more readmissions to the ICU (p=.006)
and there was a significant higher reoperation rate
(p=.0014). Furthermore, the length of stay in the ICU
was also dramatically increased in this patient group
(p=.0003).
In contrast there were no differences between the
groups in respect to gender, age at TPL, platelet count be-
fore TPL, Child stadium, incidence of diabetes mellitus,
and location before TPL (hospital/ICU/home), the rate of
marginal donor grafts, operating time, and transfusion of
RBC, FFP or platelets. For details see Table 4.
Renal failure in the group with normal baseline condition
and without postoperative RRT (group 2)
In the group 1 with RRT the mean peak creatinine level
postoperative before starting RRT was 260±98 μmol/l,
whereas in the group 2 without RRT the peak level was
136±68 μmol/l indicating that even patients without
RRT developed renal failure after TPL.
Which factors contributed to RRT in patients with
preexisting impaired kidney function before TPL (group
3, acute-on-chronic renal failure)?
In 10 of 32 patients (31.3%) with impaired baseline cre-
atinine clearance postoperatively RRT was necessary, i.e.
in 22 patients (68.7%) no RRT had to be used.
Table 3 Mortality
Mortality Group 1 Group 2 Group 3 Group 4 p-value
ICU (%) 20.0 2.4 0 0 0.008
Hospital (%) 26.7 2.4 10.0 0 0.002
Overall (%) 46.7 12.9 20.0 8.0 0.015
Comparison with Chi-Test.
Group 1: Calculated Cockcroft formula ≥ 60 ml/min with postoperative RRT.
Group 2: Calculated Cockcroft formula ≥ 60 ml/min without postoperative RRT.
Group 3: Calculated Cockcroft formula ≤ 60 ml/min with postoperative RRT.
Group 4: Calculated Cockcroft formula ≤ 60 ml/min without postoperative RRT.
Table 4 Patients with normal baseline creatinine clearance (> 60 ml/min)
Group 1 (n=15) Group 2 (n=85) p–value
Gender (m/f) 2/13 24/61 0.22
Age (yrs.) 58 (30–65) 52 (16–69) 0.39
BMI (kg/m2) 26.7 (23.2–36.0) 24.8 (16.0–36.2) 0.05
Hematocrit before TPL (%) 31.5 (15.3–40.0) 35.3 (21.7–49.6) 0.01
Platelets before TPL (103/μl) 83 (42–185) 92 (27–285) 0.32
MELD (corrected) 23 (6–31) 17 (7–33) 0.014
MELD (uncorrected) 21 (6–31) 12 (6–32) 0.13
CHILD (A/B/C in %) 23.1/30.8/46.1 35.4/41.8/22.8 0.20
Diabetes mellitus (%) 33.3% 16.8% 0.12
Admission from (Home/ward/ICU in %) 66.6/13.3/20.0 88.2/4.7/7.1 0.09
ASA class (II/III/IV in %) 6.7/53.3/40.0 11.8/61.2/27.0 0.55
Operating time (min) 390 (275–705) 355 (240–570) 0.11
Estimated intraoperative Blood loss (ml) 3000 (500–15000) 1000 (300–10000) 0.05
Marginal grafts (%) 46.7 35.3 0.40
Transfusion of – RBC (Unit) 2 (0–47) 3 (0–23) 0.36
- FFP (Unit) 12 (0–77) 12 (0–50) 0.62
- Platelets (Units) 1 (0–12) 0 (0–18) 0.37
- Fibrinogen (g) 2 (0–22) 0 (0–12) 0.08
Length of stay in ICU (days) 8 (3–54) 4 (2–31) 0.0003
Readmissions (%) 33.3 16.5 0.006
Incidence of Sepsis (%) 40.0 3.5 0.0001
Incidence of Respiratory Failure (w. reintubation) (%) 26.7 5.9 0.009
Reoperations (%) 40.0 10.6 0.001
Bilirubin peak (μmol/l) 157 (65–475) 87 (13–453) 0.003
ALT peak (U/l) 1625 (346–5147) 870 (133–7249) 0.02
AST peak (U/l) 1926 (389–10740) 1047 (114–13560) 0.02
Data expressed as median (range) or number of patients (percentage), TPL indicates transplantation, MELD model for end stage liver disease and ICU intensive
care unit, respectively.
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Univariate analysis displayed BMI (p=.028) as pre-
operative risk factor and transfusion of RBC (p=.016)
and fibrinogen (p=.039) as intraoperative risk factors for
RRT after TPL. As in the group with normal baseline
kidney function in the ICU the patients requiring RRT
postoperatively (group 3) also had significant more
sepsis (p=.021) and respiratory failure with reintubation
(p=.039); had more readmissions back to the ICU
(p=.031), showed a significant higher reoperation rate
(p=.036) and also the length of stay in the ICU was dra-
matically increased in this patient group (p=.0002).
The other analyzed factors did not differ between the
2 groups. For details see Table 5.
Discussion
As main finding this study revealed the highest mortality
rate in the group of liver transplant recipients with nor-
mal preoperative kidney function and postoperative
renal replacement therapy.
The main limitation of this study is the sample size of
only 135 patients leading to small analyzing groups (e.g.
n=15 in group 1). Therefore, the interpretation of this data
must be done very carefully. The use of Cockcroft formula
as stratifying tool has its limitation, as there is evidence
that proteinuria [27] or MDRD [28] might perform better
in pointing out renal pathology or postoperative outcome.
Unfortunately, in our retrospective patient collective there
was no routinely testing of proteinuria. Thus, we cannot
give information about the comparison and accuracy of
proteinuria and Cockcroft formula. Actually we took
Cockcroft formula because it is the easiest and most
historical and best known and used estimation for renal
function and nevertheless, its prediction of postoperative
outcome in liver transplanted recipients is of clinical
importance.
The group with acute renal failure and RRT showed also
higher MELD scores and lower pretransplant hematocrit
values than the patients without postoperative RRT and
Table 5 Patients with impaired baseline creatinine clearance (< 60 ml/min)
Group 3 (n=10) Group 4 (n=25) p-value
Gender (m/f) 10/0 20/5 0.12
Age (yrs.) 56 (36–68) 49 (23–70) 0.18
BMI (kg/m2) 26.7 (23.2–31.8) 23.7 (18.7–33.0) 0.03
Hematocrit before TPL (%) 26.8 (18.4–38.3) 28.2 (21.6–40.7) 0.56
Platelets before TPL (103/μl) 51 (40–158) 83 (22–253) 0.97
MELD (corrected) 22 (19–33) 23 (11–36) 0.55
MELD (uncorrected) 21 (19–28) 16 (6–36) 0.19
CHILD (A/B/C in %) 0/0/100 15/20/65 0.15
Diabetes mellitus (%) 10.0% 8.0% 0.85
Admission from (Home/ward/ICU in %) 30.0/40.0/30.0 60.0/28.0/12.0 0.23
ASA class (II/III/IV in %) 0/30.0/70.0 8.0/28.0/64.0 0.65
Operating time (min) 362 (250–660) 367 (260–480) 0.50
Estimated intraoperative Blood loss (ml) 3000 (200–10000) 1500 (500–8000) 0.31
Marginal grafts (%) 60 36 0.19
Transfusion of - RBC (Unit) 13 (2–39) 7 (0–20) 0.02
- FFP (Unit) 10 (0–55) 14 (0–36) 0.85
- Platelets (Units) 3 (0–6) 1 (0–12) 0.22
- Fibrinogen (g) 7 (0–22) 2 (0–20) 0.04
Length of stay in ICU (days) 10 (5–94) 4 (2–18) 0.0002
Readmissions (%) 60.0 16.0 0.03
Incidence of Sepsis (%) 20.0 0 0.02
Incidence of Respiratory Failure (w. reintubation) (%) 30.0 4.0 0.04
Reoperations (%) 50.0 12.0 0.04
Bilirubin peak (μmol/l) 128 (57–535) 119(14–568) 0.42
ALT peak (U/l) 656 (133–8492) 632 (95–4727) 0.91
AST peak (U/l) 922 (183–13805) 979 (119–4305) 0.68
Data expressed as median (range) or number of patients (percentage), TPL indicates transplantation, MELD model for end stage liver disease and ICU intensive
care unit, respectively.
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normal baseline kidney function. This might indicate
higher severity of baseline liver disease in these patients. It
is noteworthy that Weismüller et al. reported increased
postoperative creatinine levels in 56 patients with MELD
>16 versus a group with MELD <16, indicating an influ-
ence of MELD score on postoperative renal failure [29],
but in contrast Faenza et al. could not find an influence of
MELD on postoperative renal failure [7]. Potential ex-
planation for the highest mortality might be more
postoperative liver cell damage or impaired function –
indicated by elevated liver enzymes and bilirubin peak
serum levels- with consecutive multiorgan-dysfunction-syn-
drome, inclusive renal dysfunction, infections and finally
with mortality as shown in Tables 3 and 4. Therefore, the
use of marginal grafts might contribute to such a
postoperative course as described previously [30]. Our data
favors the concept that MELD score and in turn severity of
liver disease correlates with postoperative renal failure
and RRT.
Intraoperative transfusion of RBC was associated with
an increased incidence of RRT and mortality in the
group with preexisting renal failure, but not in the group
with normal renal baseline conditions.
There is strong evidence that transfusion of RBC can
compromise critically ill patients [31-33] and there are
reports, which identified intraoperative transfusion as a
risk factor for morbidity, i.e. renal failure and mortality in
liver transplant recipients [16,34,35]. On that basis, the
strategy to transfuse as few RBC intraoperatively as pos-
sible seems to be a promising concept and a high priority
aim [36,37]. More blood loss intraoperatively might lead
to reduced survival in liver TPL [38]. Interestingly, our
study group 3 had also significant more intraoperative
blood loss, which is in line with that data. After the study
by Massicotte et al. low CVP and restrictive transfusion
regime were strongly propagated [37], but the excellent
results in that study occurred in a study population with
mean MELD of 18. Whether this strategy is also as benefi-
cial in sicker patients with higher MELD scores, e.g. 21 in
our study remains still to be determined. During liver
transplantation and its long and difficult anesthesia the
patients might become hypovolemic and hypotensive
resulting in impaired organ perfusion, i.e. kidney perfusion
and in turn might contribute to postoperative renal failure
[39]. Furthermore, the reperfusion after portal unclamping
results in decreased heart rate, contractility and peripheral
vascular resistance leading also to cardiovascular instabil-
ity [40]. Therefore, the concept of “keep the patient dry”
must be examined very carefully, in particularly in regard
to the data reported by Schroeder et al., which reported
more renal failure and RRT with worse survival in a low
CVP group [41].
The two RRT groups (1 and 3) received also significant
more fibrinogen transfused. This might contribute to
renal failure because of micro embolic effects with clot-
ting appearing in the capillaries of the kidney, there is
data concerning thromboembolic events after adminis-
tration of fibrinogen [42].
Taken together, impaired kidneys seem to be more vul-
nerable to transfusion of RBC and fibrinogen than normal
kidneys. Potential explanation might be that a minimal
amount of clotting in preexisting impaired renal paren-
chyma and vasculature provokes a significant additional
organ damage resulting in renal injury.
Significant increased postoperative peak levels of ALT
and AST indicating severe hepatocellular damage were
associated with higher incidence of RRT in patients with
normal baseline kidney function. This finding might be
due to toxic or inflammatory effects of mediators released
by ischemic liver cells. Another explanation might be
hypoperfusion with impaired microcirculation in both the
liver graft and the kidneys during postoperative SIRS or
the use of marginal grafts, which is reported to increase
morbidity [43]. However, in this study we could not show
a correlation between marginal grafts and mortality.
Our data demonstrate that the complete loss of renal
function (acute renal failure) with RRT is a strong pre-
dictor of death and in turn determines outcome of liver
transplanted patients. In contrast, interestingly loss of
an “incomplete” renal function (acute-on-chronic renal
failure) seems to be of minor importance in terms to
mortality and outcome.
The fact that in 2 thirds of the patients with preexisting
renal function no RRT is necessary, gives evidence that
cautious operative strategy and prudent perioperative
management can avoid postoperative RRT. Beneficial
strategies might be intraoperatively as few transfusion of
RBC as possible [36], avoiding hypotension or hypovol-
emia [16], maybe veno-venous bypass [17,44] or piggy
back technique [45]. Postoperatively one should withhold
nephrotoxic medication if possible. There are immuno-
suppressant protocols including sirolimus or mycofenolate
mofetil-based regimes [46,47].
Conclusions
This study shows that in liver transplant recipients acute
renal failure with postoperative RRT is significantly
associated with mortality and the mortality rate is higher
than in the case of acute-on-chronic renal failure with
RRT. Furthermore, transfusion of RBC increases the risk
of RRT and mortality in acute-on-chronic renal failure.
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